Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mucin-1 (MUC1) is a high molecular weight, membrane-bound glycoprotein and a member of the mucin family. It acts as a protective barrier for epithelial surfaces. In cancer, MUC1 is frequently overexpressed with altered glycosylation patterns, contributing to tumor progression by promoting chemoresistance and metastasis. It serves as both a biomarker and a therapeutic target.
Targeted therapies under investigation include vaccines and antibody-drug conjugates directed against tumor-associated forms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mucin-1 Antigen (MUC1).